Cargando…

Early activation of deleterious molecular pathways in the kidney in experimental heart failure with atrial remodeling

Heart failure (HF) is a major health problem with worsening outcomes when renal impairment is present. Therapeutics for early phase HF may be effective for cardiorenal protection, however the detailed characteristics of the kidney in early‐stage HF (ES‐HF), and therefore treatment for potential rena...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ichiki, Tomoko, Huntley, Brenda K., Harty, Gail J., Sangaralingham, S. Jeson, Burnett, John C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430128/ https://www.ncbi.nlm.nih.gov/pubmed/28507167 http://dx.doi.org/10.14814/phy2.13283

Ejemplares similares

M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
por: McKie, Paul M, et al.
Publicado: (2013)

M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics
por: McKie, Paul M., et al.
Publicado: (2014)

A novel designer natriuretic peptide CD-NP suppresses TGF-beta 1 induced collagen Type I production in human cardiac fibroblasts
por: Ichiki, Tomoko, et al.
Publicado: (2009)

CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart
por: Martin, Fernando L., et al.
Publicado: (2012)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

C-type natriuretic peptide: the heart’s guardian angel
por: Sangaralingham, S Jeson, et al.
Publicado: (2020)

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure
por: Kawakami, Rika, et al.
Publicado: (2018)

Cenderitide, a novel dual GC-A and GC-B receptor activator, is a potent chronic cardiorenal fibroinhibiting peptide which suppresses aldosterone and reduces proteinuria in models of ardiorenal fibrosis
por: Martin, Fernando L, et al.
Publicado: (2011)

Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker
por: Tan, Nicholas Y., et al.
Publicado: (2021)

Atrial Fibrillation Underlies Cardiomyocyte Senescence and Contributes to Deleterious Atrial Remodeling during Disease Progression
por: Adili, Ailiya, et al.
Publicado: (2022)

Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure
por: Pandit, Sandeep V., et al.
Publicado: (2016)

Reverse Atrial Remodeling in Heart Failure With Recovered Ejection Fraction
por: Sun, Yuxi, et al.
Publicado: (2023)

Atrial remodelling in heart failure: recent developments and relevance for heart failure with preserved ejection fraction
por: Hohendanner, Felix, et al.
Publicado: (2018)

C-Type natriuretic peptide: a potential urinary biomarker for renal remodeling and fibrosis during aging
por: Sangaralingham, Jeson S, et al.
Publicado: (2011)

Progressive decline in circulating CNP with aging is associated with progressive cardiac fibrosis and myocardial impairment
por: Sangaralingham, Jeson, et al.
Publicado: (2009)

Heart failure-induced atrial remodelling promotes electrical and conduction alternans
por: Zhao, Na, et al.
Publicado: (2020)

Left atrial structural and mechanical remodelling in heart failure with reduced ejection fraction
por: Rossi, Andrea, et al.
Publicado: (2021)

Insights on Distinct Left Atrial Remodeling Between Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction
por: Kuo, Jen-Yuan, et al.
Publicado: (2022)

Effects of rhythm control on left atrial structure remodeling in atrial fibrillation and heart failure with preserved ejection fraction
por: Bai, Lin, et al.
Publicado: (2023)

Atrial Fibrillation Complicated by Heart Failure Induces Distinct Remodeling of Calcium Cycling Proteins
por: Lugenbiel, Patrick, et al.
Publicado: (2015)

Direct Thrombin Inhibitors Prevent Left Atrial Remodeling Associated With Heart Failure in Rats
por: Jumeau, Céline, et al.
Publicado: (2016)

Diagnostic accuracy of left atrial remodelling and natriuretic peptide levels for preclinical heart failure
por: Tsai, Jui‐Peng, et al.
Publicado: (2019)

Effect of angiotensin receptor neprilysin inhibitors on left atrial remodeling and prognosis in heart failure
por: Sun, Yuxi, et al.
Publicado: (2021)

Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
por: Correale, Michele, et al.
Publicado: (2023)

Deleterious effects of catecholamine administration in acute heart failure caused by unrecognized Takotsubo cardiomyopathy
por: Dandel, Michael, et al.
Publicado: (2018)

Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation
por: Molina, Cristina E., et al.
Publicado: (2018)

Drastic Cardiac Reverse Remodeling Following Catheter Ablation in Patients with Atrial Fibrillation and Heart Failure
por: Koi, Takahisa, et al.
Publicado: (2021)

Sialomucin CD43 Plays a Deleterious Role in the Development of Experimental Heart Failure Induced by Pressure Overload by Modulating Cardiac Inflammation and Fibrosis
por: Kaur, Kuljeet, et al.
Publicado: (2021)

A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
por: Lim, Soo Ghim, et al.
Publicado: (2013)

Effects of Trandolapril on Structural, Contractile and Electrophysiological Remodeling in Experimental Volume Overload Heart Failure
por: Jarkovská, Dagmar, et al.
Publicado: (2021)

Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure
por: Joshi, Sachindra R., et al.
Publicado: (2023)

The good and the ugly: ANP antagonizes the deleterious effects of aldosterone in hypertensive cardiac remodeling
por: Nakagawa, Hitoshi, et al.
Publicado: (2013)

Preventive Effects of the Angiotensin-II Receptor Blocker on Atrial Remodeling in an Ischemic Heart Failure Model of Rats
por: Yoon, Namsik, et al.
Publicado: (2013)

Left atrial reverse remodeling improves risk stratification in patients with heart failure with recovered ejection fraction
por: Shiba, Masayuki, et al.
Publicado: (2022)

Atrial Fibrillation and Heart Failure
por: Bergau, Leonard, et al.
Publicado: (2022)

The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling
por: Andenæs, Kine, et al.
Publicado: (2018)

Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2019)

Metformin Counteracts the Deleterious Effects of Methylglyoxal on Ovalbumin-Induced Airway Eosinophilic Inflammation and Remodeling
por: Medeiros, Matheus L., et al.
Publicado: (2023)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Metabolic remodeling induced by mitokines in heart failure
por: Duan, Jiahao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_340ono2ieqmomvibsbcqpo1s4p